Accueil › Cancer du poumon non à petites cellules › Texas › League City
Essais cliniques pour Cancer du poumon non à petites cellules à League City, TX
15 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de League City (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Recrutement en coursPhase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Recrutement en coursPhase 3
- University Of Texas Medical Branch At Galveston, Galveston · à 23 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
- Texas Oncology - Gulf Coast, Webster · à 3 mi
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Kelsey-Seybold Clinic - Bay Area Campus Building A, Webster · à 3 mi
- Kelsey-Seybold Clinic - Bay Area Campus Building B, Webster · à 3 mi
- Kelsey-Seybold Clinic - Bay Area Campus Building C, Webster · à 3 mi
- et 1 autres
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 2
- Texas Oncology-Gulf Coast, Webster · à 3 mi
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Research Site, Galveston · à 23 mi
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 2
- University of Texas Medical Branch, Galveston · à 23 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Recrutement en coursPhase 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Recrutement en coursPhase 3
- Local Institution - 0692, Galveston · à 23 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recrutement en coursPhase 3
- Clinical Study Site, Webster · à 3 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- USO - Texas Oncology, Webster · à 3 mi
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Research Site, Webster · à 3 mi
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Recrutement en coursPhase 1
- Tranquil Clinical Research, Webster · à 3 mi
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 2
- MD Anderson League City, League City
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Recrutement en cours
- University of Texas Medical Branch at Galveston, Galveston · à 23 mi
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY121 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH57 études
- Washington, DC55 études
Autres études à League City
- Cancer du sein12 études
- Cancer métastatique7 études
- Colite ulcéreuse6 études
- Cancer du poumon6 études
- Cancer colorectal6 études
- Cancer (tous types)5 études
- Cancer de l'ovaire5 études
- Accident vasculaire cérébral5 études
- Cancer de la vessie4 études
- Carcinome épidermoïde de la tête et du cou4 études
- Cancer de la prostate4 études
- Conditions post-COVID (COVID long)3 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.